iPPI-DB

Inhibitors of Protein-Protein Interaction Database

Compound 128

Identifiers

  • Canonical SMILES: 
    Cc1ccc(cc1C)-c1nc(C(N)=O)c(-c2cccc(Cl)c2)n1-c1cc(Cl)ccc1C
  • InChi: 
    InChI=1S/C25H21Cl2N3O/c1-14-7-9-18(11-16(14)3)25-29-22(24(28)31)23(17-5-4-6-19(26)12-17)30(25)21-13-20(27)10-8-15(21)2/h4-13H,1-3H3,(H2,28,31)
  • InChiKey: 
    HQDXXKMWEXNZQE-UHFFFAOYSA-N

External links


69945341

External search

Bibliography (1)

Publication Name
Guido Bold, Pascal Furet, François GESSIER, Joerg Kallen, Lisztwan Joanna Hergovich, Keiichi Masuya, Andrea Vaupel, Novartis Ag. . Tetra-substituted heteroaryl compounds and their use as mdm2 and/or mdm4 modulators None. 4

Pharmacological data

Biochemical tests Cellular tests PK tests Cytotoxicity tests
1 0 0 0

Targets

PPI family Best activity Diseases MMoA
MDM2-Like / P53 6.02 cancer Inhibition
Physicochemical filters
Descriptor Lipinski's RO5 Veber Pfizer's 3/75
Compliance
MW 449.11 g/mol
HBA 4
HBD 2
HBA + HBD 6
AlogP 6.39
TPSA 60.91
RB 3
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources Biochemical tests Cellular tests PK tests Cytotoxicity tests
1 1 0 0 0
Pharmacological data
Bibliography Name Target Competition Assay type Assay name Cell line Activity type Activity
WO2011023677 4 MDM2
Q00987
Biochemical assay Fluorescence Polarization pIC50 (half maximal inhibitory concentration, -log10) 6.02
Ta Structure Name Drugbank ID
0.4570 AZD-7687 DB14949
0.4514 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide DB03509
0.4504 Flumazenil DB01205
0.4498 Azeliragon DB12689
0.4440 Iomazenil DB14971
0.4318 Conivaptan DB00872
0.4258 Cimicoxib DB05095
0.4128 Miransertib DB14982
0.4078 N-6022 DB12206
0.4067 Telmisartan DB00966
0.4049 L-778123 DB07227
0.3946 ONT-093 DB14069
0.3930 Otenabant DB11745
0.3927 4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE DB07607
0.3884 Midazolam DB00683